BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.

Scolyer RA, Atkinson V, Gyorki DE, Lambie D, O'Toole S, Saw RPM, Amanuel B, Angel CM, Button-Sloan AE, Carlino MS, Ch'ng S, Colebatch AJ, Daneshvar D, Pires da Silva I, Dawson T, Ferguson PM, Foster-Smith E, Fox SB, Gill AJ, Gupta R, Henderson MA, Hong AM, Howle JR, Jackett LA, James C, Lee CS, Lochhead A, Loh D, McArthur GA, McLean CA, Menzies AM, Nieweg OE, O'Brien BH, Pennington TE, Potter AJ, Prakash S, Rawson RV, Read RL, Rtshiladze MA, Shannon KF, Smithers BM, Spillane AJ, Stretch JR, Thompson JF, Tucker P, Varey AHR, Vilain RE, Wood BA, Long GV

Open source

DOI
10.1016/j.pathol.2021.11.002
Published
2022 Feb
Container
Pathology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pathol.2021.11.002,
  title = {BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.},
  author = {Scolyer RA and Atkinson V and Gyorki DE and Lambie D and O'Toole S and Saw RPM and Amanuel B and Angel CM and Button-Sloan AE and Carlino MS and Ch'ng S and Colebatch AJ and Daneshvar D and Pires da Silva I and Dawson T and Ferguson PM and Foster-Smith E and Fox SB and Gill AJ and Gupta R and Henderson MA and Hong AM and Howle JR and Jackett LA and James C and Lee CS and Lochhead A and Loh D and McArthur GA and McLean CA and Menzies AM and Nieweg OE and O'Brien BH and Pennington TE and Potter AJ and Prakash S and Rawson RV and Read RL and Rtshiladze MA and Shannon KF and Smithers BM and Spillane AJ and Stretch JR and Thompson JF and Tucker P and Varey AHR and Vilain RE and Wood BA and Long GV},
  year = {2022},
  journal = {Pathology},
  doi = {10.1016/j.pathol.2021.11.002},
  url = {https://doi.org/10.1016/j.pathol.2021.11.002}
}

RIS

TY  - JOUR
TI  - BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.
AU  - Scolyer RA
AU  - Atkinson V
AU  - Gyorki DE
AU  - Lambie D
AU  - O'Toole S
AU  - Saw RPM
AU  - Amanuel B
AU  - Angel CM
AU  - Button-Sloan AE
AU  - Carlino MS
AU  - Ch'ng S
AU  - Colebatch AJ
AU  - Daneshvar D
AU  - Pires da Silva I
AU  - Dawson T
AU  - Ferguson PM
AU  - Foster-Smith E
AU  - Fox SB
AU  - Gill AJ
AU  - Gupta R
AU  - Henderson MA
AU  - Hong AM
AU  - Howle JR
AU  - Jackett LA
AU  - James C
AU  - Lee CS
AU  - Lochhead A
AU  - Loh D
AU  - McArthur GA
AU  - McLean CA
AU  - Menzies AM
AU  - Nieweg OE
AU  - O'Brien BH
AU  - Pennington TE
AU  - Potter AJ
AU  - Prakash S
AU  - Rawson RV
AU  - Read RL
AU  - Rtshiladze MA
AU  - Shannon KF
AU  - Smithers BM
AU  - Spillane AJ
AU  - Stretch JR
AU  - Thompson JF
AU  - Tucker P
AU  - Varey AHR
AU  - Vilain RE
AU  - Wood BA
AU  - Long GV
PY  - 2022
JO  - Pathology
DO  - 10.1016/j.pathol.2021.11.002
UR  - https://doi.org/10.1016/j.pathol.2021.11.002
ER  -

APA

RA, S., V, A., DE, G., D, L., S, O., RPM, S., B, A., CM, A., AE, B., MS, C., S, C., AJ, C., D, D., I, P. D. S., T, D., PM, F., E, F., SB, F., AJ, G., R, G., MA, H., AM, H., JR, H., LA, J., C, J., CS, L., A, L., D, L., GA, M., CA, M., AM, M., OE, N., BH, O., TE, P., AJ, P., S, P., RV, R., RL, R., MA, R., KF, S., BM, S., AJ, S., JR, S., JF, T., P, T., AHR, V., RE, V., BA, W., & GV, L. (2022). BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.. Pathology. https://doi.org/10.1016/j.pathol.2021.11.002

Source records